sorafenib has been researched along with Cancer of Parathyroid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, A; Asayama, I; Kanasaki, K; Makino, H; Miyake, H; Morita, M; Nakao, M; Notsu, M; Otani, H; Uchino, S; Yamamoto, M; Yamauchi, M | 1 |
1 other study(ies) available for sorafenib and Cancer of Parathyroid
| Article | Year |
|---|---|
Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma.
Topics: Denosumab; Humans; Hypercalcemia; Male; Middle Aged; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Sorafenib | 2022 |